Lusimbo, Richard2026-07-302026-07-302026-03-09Lusimbo, R. (2026). Who gets access and how fast will determine Lenacapavir's impact. Daily Monitor.https://bdears.busitema.ac.ug/handle/123456789/8437Newspaper articleLong-acting HIV prevention options like Lenacapavir are genuine game changer for communities facing stigma, legal barriers, and daily adherence challenges. For a young woman navigating an abusive relationship, or sex worker afraid to be seen at a clinic, a twice-yearly injection removes many of the barriers that daily prevention pills cannot overcome.enArticle